Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOSARTAN vs LOVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOSARTAN vs LOVASTATIN: Safety Overview

Metric LOSARTAN LOVASTATIN
Total FAERS Reports 21,916 1,387
Deaths Reported 2,034 204
Death Rate 9.3% 14.7%
Hospitalizations 7,032 287
Average Patient Age 65.2 yrs 60.2 yrs
% Female Patients 59.8% 55.9%
FDA Approval Date Apr 14, 1995 Apr 14, 2006
Manufacturer Aphena Pharma Solutions - Tennessee, LLC Preferred Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued